Celldex Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
CLDX
CUSIP
15117B202
Type
Equity
Class
COM NEW
Num filings
165
Total reported value, excl. options
$1.70 B
Manager Report Date Value ($000) Shares Option Type